3 Stocks I’m Buying (June 2021)

New month, new investment opportunities. Below are three stocks I’m buying in June, 2021. Feel free to take a look at these picks and see if any of them match your own portfolio goals.

1. Bristol-Myers Squibb Company (BMY)

Healthcare stocks are trading cheaply. Many of these profitable, successful businesses are trading at valuations on par with tobacco companies. Pfizer, Abbvie, and Bristol-Myers Squibb all have very low PE ratios.

For whatever reason, Wall Street is pricing major pharmaceutical makers at zero growth.

Something similar happened to Lockheed-Martin around 2009- 2010. The stock has grown over 400% since. I don’t know if Bristol-Myers Squibb will skyrocket like this, but I do think it’s a rare example of a “wonderful business at a wonderful price.”

Right now, Bristol-Myers Squibb has three of the world’s top five best-selling drugs: Revlimid, Eliquis, and Opdivo.

While several of these patents will expire soon, the company has new drugs coming online as well.

Bristol-Myers Squib acquired cancer treatment firm Celgene in 2019. This has given Bristol-Myers Squibb a huge pipeline of new drugs such as Reblozyl (Estimated peak sales: $2 billion) and Inrebic (a niche blood cancer drug with only one…